𝔖 Bobbio Scriptorium
✦   LIBER   ✦

New Antimitotic Agents with Activity in Multi-Drug-Resistant Cell Lines and in Vivo Efficacy in Murine Tumor Models

✍ Scribed by Szczepankiewicz, Bruce G.; Liu, Gang; Jae, Hwan-Soo; Tasker, Andrew S.; Gunawardana, Indrani W.; von Geldern, Thomas W.; Gwaltney, Stephen L.; Wu-Wong, J. Ruth; Gehrke, Laura; Chiou, William J.; Credo, R. Bruce; Alder, Jeffery D.; Nukkala, Michael A.; Zielinski, Nicolette A.; Jarvis, Ken; Mollison, Karl W.; Frost, David J.; Bauch, Joy L.; Hui, Yu Hua; Claiborne, Akiyo K.; Li, Qun; Rosenberg, Saul H.


Book ID
118069557
Publisher
American Chemical Society
Year
2001
Tongue
English
Weight
224 KB
Volume
44
Category
Article
ISSN
0022-2623

No coin nor oath required. For personal study only.


πŸ“œ SIMILAR VOLUMES


In vivo anti-tumor activity of combinati
✍ Michael J. Brunda; Donna Bellantoni; Viveca Sulich πŸ“‚ Article πŸ“… 1987 πŸ› John Wiley and Sons 🌐 French βš– 684 KB

The in vivo anti-tumor activity of 2 recombinant cytokines, interleukin-2 (rlL-2) and human hybrid interferon alpha (rHulFN-aA/D), were tested using the murine reticulum cell sarcoma M5076. Experimental hepatic metastases, following i.v. injection of tumor cells, and tumor growth and spontaneous met

Effect of IFN-Ξ³ treatment and in vivo pa
✍ Li Tsai; Claes Γ–hlΓ©n; Hans-Gustaf Ljunggren; Klas KΓ€rre; Mona Hansson; Rolf Kies πŸ“‚ Article πŸ“… 1989 πŸ› John Wiley and Sons 🌐 French βš– 555 KB

Interferon-gamma (IFN-y) treatment or in vivo passage of the murine YAC-I lymphoma resulted in reduced sensitivity to in vitro lysis by syngeneic murine spleen cells cultured in rll-2 (LAK-cells). IFN-y treatment also rendered the murine B16 melanoma less sensitive to lysis by syngeneic LAK cells, w